Clinuvel (CUV) is held by 5 ASX ETFs. Over the last 3 months it fell 25.3%: on $10,000, −$2532. We explain 3 big moves in that time.
About CUV
- SectorHealth Care
- IndustryPharmaceuticals, Biotechnology & Life Sciences
- Size$406.4m
- Held by5 ETFs
- Big moves3 in 3M
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- +2.7%peak +3.6%1 Sep 2026· Operational
Clinuvel's announcement that it is considering a Nasdaq listing and potential ASX delisting spooked ASX investors, triggering a sell-off on elevated volume several days after the news dropped.
- −12.7%peak −18.5%27 Aug 2026· Earnings Miss
Clinuvel's FY26 full-year results disappointed the market, triggering a sharp sell-off despite a decade of profitability headline, as investors reacted negatively to the actual numbers or forward outlook in the annual report and preliminary final report released minutes before the price move.
- +5.8%peak +6.3%18 Aug 2026· Sector Flow
CUV rose sharply as the broader ASX healthcare sector surged strongly on the same day, lifting sector peers including CUV.
Held by 5 ETFs
Of every $10,000 in each fund, how much is in CUV today.
Why did CUV rise 5.8% on 18 Aug 2026?
Clinuvel
CUV rose sharply as the broader ASX healthcare sector surged strongly on the same day, lifting sector peers including CUV.
There are no company-specific announcements, news articles, or peer signals to explain an idiosyncratic move. The strongest evidence is the GICS Health sector index (^AXHJ) rising 6.59% on the same day — well above its normal daily range at 5.5x ATR — with a confirmed direction match. CUV's 5.1% gain is consistent with a beta-driven sector lift rather than a stock-specific catalyst. The moderate volume ratio (1.66x) supports broad sector buying rather than targeted accumulation, and the absence of any news or announcements reinforces a sector-flow explanation.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice. It does not consider your objectives, finances or needs. Past performance is not a guide to future performance.
Evidence
Sector / macro signals
What it did to the 5 ETFs holding CUV
On $10,000 in each fund, at the weight it holds today